Researchers at the Universidad de Murcia have developed plant-based functional pet food supplements, including a phytomelatonin-based immune activator and herbal palatability enhancers. These innovations, designed to improve pet health and food appeal, have been validated for stability in commercial dry pet food manufacturing.
The Universidad de Murcia (UMU), through its Knowledge Transfer Group Soluciones Vegetales, has developed a line of functional, plant-based supplements to enhance pet nutrition and well-being. These innovations, created in collaboration with the company Alinatur Petfood, include specialized solutions to address diverse pet health needs, such as stress reduction, dental hygiene, joint support, and digestive health. A primary focus of this research is the creation of natural, effective additives that remain stable during the manufacturing process of pet food.
The technological developments include:
The technology has reached a maturity level of 8. The research project has successfully moved from conceptual formulation to successful integration and testing within industrial manufacturing processes. The developed formulations have been transferred to the industry partner for commercial development, with direct applications in the pet food market.
Universidad de Murcia is a large, comprehensive public research university in southeast Spain, serving the Region of Murcia with broad academic and research programs. Industry engagement is supported by a research and technology park and campus core facilities, plus proximity to the region’s agri‑food innovation cluster, enabling partners to co‑develop and test solutions. The university’s integration with the regional health system and an affiliated teaching hospital facilitates clinical studies and translational collaborations. Research is backed by competitive European and national funding, including programs from the European Commission and Spain’s national research agency, alongside regional and industry contracts. A technology transfer office manages IP, licensing, spinouts, and collaboration agreements for streamlined access by corporate R&D.